Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00398619 · ClinicalTrials.gov registry record · Phase 1
A Study of the Effect of INCB013739 on Cortisone Reducing Enzyme Activity in Obese People Predisposed to Diabetes
A Phase 1 study, sponsored by Incyte Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00398619: Completed Phase 1 study, sponsored by Incyte Corporation.
NCT00398619 is a Phase 1 study that has completed, run by Incyte Corporation. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00398619, a Phase 1 study, has completed, sponsored by Incyte Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this study is to determine whether the investigational drug INCB013739 has an effect on systemic and adipose tissue 11-HSD1 activity in obese, insulin resistant subjects.
Interventions
- DRUG INCB13739
Trial Details
| Field | Value |
|---|---|
| Start Date | 2006-11 |
| Est. Completion | 2007-03 |
| Phase | Phase 1 |
What the finished NCT00398619 record still lists
NCT00398619 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which INCB13739 is the first listed.
NCT00398619 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00398619 about?
NCT00398619 is a clinical study titled "A Study of the Effect of INCB013739 on Cortisone Reducing Enzyme Activity in Obese People Predisposed to Diabetes". The purpose of this study is to determine whether the investigational drug INCB013739 has an effect on systemic and adipose tissue 11-HSD1 activity in obese, insulin resistant subjects.
What is the current status of trial NCT00398619?
This trial is currently completed. It is a Phase 1 study. The study started on 2006-11. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00398619?
The interventions under investigation include: INCB13739 (DRUG).
Who is sponsoring clinical trial NCT00398619?
This trial is sponsored by Incyte Corporation, which has 239 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia